UnitedHealth Group Abandons Two Acquisitions Following Antitrust Division Scrutiny
UnitedHealth Group has abandoned its proposed acquisitions of Stewardship Health Inc. and a related company, following intense scrutiny from the Justice Department’s Antitrust Division. This decision comes amidst growing concerns about the potential impact of these transactions on healthcare quality, costs, and working conditions for medical professionals.
Assistant Attorney General Jonathan Kanter of the Justice Department’s Antitrust Division released a statement highlighting the significance of the Antitrust Division’s role in this outcome. “When you ask Americans what keeps them up at night, affording and accessing quality health care is too often at the top of their list,” Kanter stated. He emphasized that these proposed acquisitions by UnitedHealth Group, which is one of the largest healthcare companies in the United States, raised serious questions about their potential effects on the quality and cost of care, as well as the working conditions for doctors, nurses, and other healthcare providers.
Kanter expressed his gratitude towards the Antitrust Division’s team for their diligent efforts. “I am grateful for the Antitrust Division’s lawyers, economists, paralegals and professional staff who are tireless in their commitment to identify and address pressing antitrust problems in healthcare markets,” he said.
Read more: UnitedHealth Faces Antitrust Lawsuit Over Alleged Misconduct Post Change Healthcare Acquisition
The abandonment of these acquisitions marks a significant moment in the ongoing scrutiny of mergers and acquisitions in the healthcare sector. It underscores the Justice Department’s commitment to ensuring that such transactions do not harm consumers or undermine the quality of healthcare services.
UnitedHealth Group has yet to release a detailed statement regarding their decision to withdraw from these deals. However, the company’s actions reflect the increasing pressure and regulatory hurdles facing large healthcare providers as they seek to expand their market presence.
The scrutiny of these acquisitions is part of a broader effort by the Antitrust Division to maintain competitive markets and prevent monopolistic practices that could disadvantage consumers and healthcare professionals.
Source: Justice Gov
Featured News
Electrolux Fined €44.5 Million in French Antitrust Case
Dec 19, 2024 by
CPI
Indian Antitrust Body Raids Alcohol Giants Amid Price Collusion Probe
Dec 19, 2024 by
CPI
Attorneys Seek $525 Million in Fees in NCAA Settlement Case
Dec 19, 2024 by
CPI
Italy’s Competition Watchdog Ends Investigation into Booking.com
Dec 19, 2024 by
CPI
Minnesota Judge Approves $2.4 Million Hormel Settlement in Antitrust Case
Dec 19, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 19, 2024 by
CPI
Effective Interoperability in Mobile Ecosystems: EU Competition Law Versus Regulation
Dec 19, 2024 by
Giuseppe Colangelo
The Use of Empirical Evidence in Antitrust: Trends, Challenges, and a Path Forward
Dec 19, 2024 by
Eliana Garces
Some Empirical Evidence on the Role of Presumptions and Evidentiary Standards on Antitrust (Under)Enforcement: Is the EC’s New Communication on Art.102 in the Right Direction?
Dec 19, 2024 by
Yannis Katsoulacos
The EC’s Draft Guidelines on the Application of Article 102 TFEU: An Economic Perspective
Dec 19, 2024 by
Benoit Durand